Published in J Thorac Dis on August 01, 2013
Rituximab in autoimmune diseases. Aust Prescr (2016) 0.77
An Unusual Case of Cystic Fibrosis Associated Pneumocystis jiroveci Pneumonia in an Infant. Case Rep Infect Dis (2016) 0.75
Prophylaxis and Treatment of Pneumocystis jiroveci Pneumonia in Lymphoma Patients Subjected to Rituximab-Contained Therapy: A Systemic Review and Meta-Analysis. PLoS One (2015) 0.75
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med (2004) 14.53
Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy. Mayo Clin Proc (1996) 2.65
B cells are required for generation of protective effector and memory CD4 cells in response to Pneumocystis lung infection. J Immunol (2006) 1.86
Rituximab-associated infections. Semin Hematol (2010) 1.83
Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials. Mayo Clin Proc (2007) 1.73
High incidence of Pneumocystis jirovecii pneumonia in patients receiving biweekly rituximab and cyclophosphamide, adriamycin, vincristine, and prednisone. Leuk Lymphoma (2010) 1.64
Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital. JAMA (1992) 1.32
Atypical Pneumocystis jiroveci pneumonia with multiple nodular granulomas after rituximab for refractory nephrotic syndrome. Pediatr Nephrol (2012) 1.12
Pneumocystis jiroveci pneumonia in relation to CD4+ lymphocyte count in patients with B-cell non-Hodgkin lymphoma treated with chemotherapy. Leuk Lymphoma (2010) 1.09
Late onset Pneumocystis pneumonia in patients receiving rituximab for humoral renal transplant rejection. Nephrology (Carlton) (2009) 1.04
Pneumocystis jirovecii pneumonia in B-cell lymphoma patients treated with the rituximab-CHOEP-14 regimen. Haematologica (2007) 1.03
Two cases of Pneumocystis jiroveci pneumonia with non-Hodgkin's lymphoma after CHOP-based chemotherapy containing rituximab. J Clin Exp Hematop (2010) 1.01
Pneumocystis jiroveci pneumonia following rituximab treatment in Wegener's granulomatosis. Arthritis Care Res (Hoboken) (2010) 0.99
Addition of rituximab to cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy has a high risk of developing interstitial pneumonia in patients with non-Hodgkin lymphoma. Leuk Lymphoma (2009) 0.98
An analysis of the utilisation of chemoprophylaxis against Pneumocystis jirovecii pneumonia in patients with malignancy receiving corticosteroid therapy at a cancer hospital. Br J Cancer (2005) 0.97
Increased incidence of interstitial pneumonia by CHOP combined with rituximab. Int J Hematol (2008) 0.95
Granulomatous Pneumocystis jiroveci pneumonia in a patient with diffuse large B-cell lymphoma: case report and review of the literature. Acta Haematol (2009) 0.94
Three cases of Pneumocystis jirovecii pneumonia (PCP) during first-line treatment with rituximab in combination with CHOP-14 for aggressive B-cell non-Hodgkin's lymphoma. Eur J Haematol (2007) 0.92
Combined trimethoprim and caspofungin treatment for severe Pneumocystis jiroveci pneumonia in a five year old boy with acute lymphoblastic leukemia. Klin Padiatr (2006) 0.90
Chronic Pneumocystis jiroveci presenting as asymptomatic granulomatous pulmonary nodules in lymphoma. J Infect (2011) 0.89
Pneumocystis jiroveci pneumonia in patients with systemic lupus erythematosus after rituximab therapy. Lupus (2012) 0.89
The increased risk for pneumocystis pneumonia in patients receiving rituximab-CHOP-14 can be prevented by the administration of trimethoprim/sulfamethoxazole: a single-center experience. Acta Haematol (2011) 0.85
Susceptibility of Pneumocystis to echinocandins in suspension and biofilm cultures. Antimicrob Agents Chemother (2011) 0.84
Point prevalence of Pneumocystis pneumonia in patients with non-Hodgkin lymphoma according to the number of cycles of R-CHOP chemotherapy. Ann Hematol (2012) 0.83
A trial of caspofungin salvage treatment in PCP pneumonia. Thorax (2010) 0.81
Pneumocystis jiroveci pneumonia in patients with non-Hodgkin's lymphoma receiving chemotherapy containing rituximab. J Chin Med Assoc (2008) 0.80
[The treatment of pneumocystis Carinii pneumonia with caspofungin in elderly patients: a case report and literature review]. Zhonghua Jie He He Hu Xi Za Zhi (2006) 0.80
Interstitial pneumonia after autologous hematopoietic stem cell transplantation in B-cell non-hodgkin lymphoma. Clin Lymphoma Myeloma Leuk (2011) 0.79
Severe pulmonary adverse effects in lymphoma patients treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus rituximab. Korean J Intern Med (2010) 0.79
Low absolute lymphocyte count and addition of rituximab confer high risk for interstitial pneumonia in patients with diffuse large B-cell lymphoma. Ann Hematol (2011) 0.78
CIP2A inhibits PP2A in human malignancies. Cell (2007) 5.28
Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nat Med (2011) 4.68
Mechanisms of gamma oscillations. Annu Rev Neurosci (2012) 4.58
A recurrent network mechanism of time integration in perceptual decisions. J Neurosci (2006) 4.53
Cortico-basal ganglia circuit mechanism for a decision threshold in reaction time tasks. Nat Neurosci (2006) 4.36
What determines the frequency of fast network oscillations with irregular neural discharges? I. Synaptic dynamics and excitation-inhibition balance. J Neurophysiol (2003) 3.54
Neuronal basis of age-related working memory decline. Nature (2011) 3.15
The importance of mixed selectivity in complex cognitive tasks. Nature (2013) 3.05
Induction of sonic hedgehog mediators by transforming growth factor-beta: Smad3-dependent activation of Gli2 and Gli1 expression in vitro and in vivo. Cancer Res (2007) 3.02
Cellular and network mechanisms of slow oscillatory activity (<1 Hz) and wave propagations in a cortical network model. J Neurophysiol (2003) 2.92
Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-α in rheumatoid arthritis. Nat Med (2013) 2.85
Interneuron Diversity series: Circuit complexity and axon wiring economy of cortical interneurons. Trends Neurosci (2004) 2.68
A strong ferroelectric ferromagnet created by means of spin-lattice coupling. Nature (2010) 2.63
NMDA receptors subserve persistent neuronal firing during working memory in dorsolateral prefrontal cortex. Neuron (2013) 2.46
Loss of transforming growth factor-beta type II receptor promotes metastatic head-and-neck squamous cell carcinoma. Genes Dev (2006) 2.46
Retracted Crucial role of interleukin-7 in T helper type 17 survival and expansion in autoimmune disease. Nat Med (2010) 2.43
Variance as a signature of neural computations during decision making. Neuron (2011) 2.42
Smad7-induced beta-catenin degradation alters epidermal appendage development. Dev Cell (2006) 2.41
Two calcium-dependent protein kinases, CPK4 and CPK11, regulate abscisic acid signal transduction in Arabidopsis. Plant Cell (2007) 2.40
The role of default network deactivation in cognition and disease. Trends Cogn Sci (2012) 2.39
Genome-wide association identifies a susceptibility locus for coronary artery disease in the Chinese Han population. Nat Genet (2011) 2.32
Smad7 binds to the adaptors TAB2 and TAB3 to block recruitment of the kinase TAK1 to the adaptor TRAF2. Nat Immunol (2007) 2.09
Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis. J Clin Invest (2005) 1.98
Smad4 loss in mice causes spontaneous head and neck cancer with increased genomic instability and inflammation. J Clin Invest (2009) 1.95
Similarity effect and optimal control of multiple-choice decision making. Neuron (2008) 1.88
Keratinocyte-specific Smad2 ablation results in increased epithelial-mesenchymal transition during skin cancer formation and progression. J Clin Invest (2008) 1.88
Robust spatial working memory through homeostatic synaptic scaling in heterogeneous cortical networks. Neuron (2003) 1.85
Neural circuit dynamics underlying accumulation of time-varying evidence during perceptual decision making. Front Comput Neurosci (2007) 1.85
Targeted disruption of TGF-beta/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma. Am J Pathol (2004) 1.77
Latent TGFbeta1 overexpression in keratinocytes results in a severe psoriasis-like skin disorder. EMBO J (2004) 1.75
A biophysically based neural model of matching law behavior: melioration by stochastic synapses. J Neurosci (2006) 1.72
Overexpression of transforming growth factor beta1 in head and neck epithelia results in inflammation, angiogenesis, and epithelial hyperproliferation. Cancer Res (2004) 1.71
The stability of a stochastic CaMKII switch: dependence on the number of enzyme molecules and protein turnover. PLoS Biol (2005) 1.70
Neural dissociation of delay and uncertainty in intertemporal choice. J Neurosci (2008) 1.68
Transforming growth factor-β signaling promotes pulmonary hypertension caused by Schistosoma mansoni. Circulation (2013) 1.68
A recurrent network model of somatosensory parametric working memory in the prefrontal cortex. Cereb Cortex (2003) 1.66
A reservoir of time constants for memory traces in cortical neurons. Nat Neurosci (2011) 1.66
IKKalpha is a critical coregulator of a Smad4-independent TGFbeta-Smad2/3 signaling pathway that controls keratinocyte differentiation. Proc Natl Acad Sci U S A (2008) 1.66
Role of osteopontin in synovial Th17 differentiation in rheumatoid arthritis. Arthritis Rheum (2010) 1.62
A specialized NMDA receptor function in layer 5 recurrent microcircuitry of the adult rat prefrontal cortex. Proc Natl Acad Sci U S A (2008) 1.61
A neural circuit model of flexible sensorimotor mapping: learning and forgetting on multiple timescales. Neuron (2007) 1.56
Design, preparation, and characterization of high-activity mutants of human butyrylcholinesterase specific for detoxification of cocaine. Mol Pharmacol (2010) 1.48
Contributions of intrinsic membrane dynamics to fast network oscillations with irregular neuronal discharges. J Neurophysiol (2005) 1.42
Genome-wide expression profiling of five mouse models identifies similarities and differences with human psoriasis. PLoS One (2011) 1.41
Temporally irregular mnemonic persistent activity in prefrontal neurons of monkeys during a delayed response task. J Neurophysiol (2003) 1.41
Inducible activation of oncogenic K-ras results in tumor formation in the oral cavity. Cancer Res (2004) 1.40
Angular path integration by moving "hill of activity": a spiking neuron model without recurrent excitation of the head-direction system. J Neurosci (2005) 1.39
Characterization of a high-activity mutant of human butyrylcholinesterase against (-)-cocaine. Chem Biol Interact (2010) 1.39
Leukemia inhibitory factor inhibits T helper 17 cell differentiation and confers treatment effects of neural progenitor cell therapy in autoimmune disease. Immunity (2011) 1.38
Internal representation of task rules by recurrent dynamics: the importance of the diversity of neural responses. Front Comput Neurosci (2010) 1.37
Synaptic computation underlying probabilistic inference. Nat Neurosci (2009) 1.36
Mean-driven and fluctuation-driven persistent activity in recurrent networks. Neural Comput (2007) 1.35
Critical and reciprocal regulation of KLF4 and SLUG in transforming growth factor β-initiated prostate cancer epithelial-mesenchymal transition. Mol Cell Biol (2011) 1.34
NMDA receptor function in large-scale anticorrelated neural systems with implications for cognition and schizophrenia. Proc Natl Acad Sci U S A (2012) 1.32
The dynamical stability of reverberatory neural circuits. Biol Cybern (2002) 1.30
Proactive inhibitory control and attractor dynamics in countermanding action: a spiking neural circuit model. J Neurosci (2009) 1.29
A patient tumor transplant model of squamous cell cancer identifies PI3K inhibitors as candidate therapeutics in defined molecular bins. Mol Oncol (2013) 1.28
A neural circuit basis for spatial working memory. Neuroscientist (2004) 1.28
An integrated microcircuit model of attentional processing in the neocortex. J Neurosci (2007) 1.28
Overexpression of Smad7 results in severe pathological alterations in multiple epithelial tissues. EMBO J (2002) 1.25
The dynamical response properties of neocortical neurons to temporally modulated noisy inputs in vitro. Cereb Cortex (2008) 1.22
Essential roles of BMPR-IA signaling in differentiation and growth of hair follicles and in skin tumorigenesis. Genesis (2004) 1.22
A catenated strut in a catenated metal-organic framework. Angew Chem Int Ed Engl (2010) 1.22
The cytokine milieu in the interplay of pathogenic Th1/Th17 cells and regulatory T cells in autoimmune disease. Cell Mol Immunol (2010) 1.21
From distributed resources to limited slots in multiple-item working memory: a spiking network model with normalization. J Neurosci (2012) 1.20
Inhibitory control by an integral feedback signal in prefrontal cortex: a model of discrimination between sequential stimuli. Proc Natl Acad Sci U S A (2005) 1.20
Carbon monoxide enhances salt tolerance by nitric oxide-mediated maintenance of ion homeostasis and up-regulation of antioxidant defence in wheat seedling roots. Plant Cell Environ (2008) 1.20
Overexpression of microRNA OsmiR397 improves rice yield by increasing grain size and promoting panicle branching. Nat Biotechnol (2013) 1.20
Bursting neurons signal input slope. J Neurosci (2002) 1.17
A mechanical actuator driven electrochemically by artificial molecular muscles. ACS Nano (2009) 1.16
Integrated materials design of organic semiconductors for field-effect transistors. J Am Chem Soc (2013) 1.16
Neural mechanism for stochastic behaviour during a competitive game. Neural Netw (2006) 1.15
In utero activation of K5.CrePR1 induces gene deletion. Genesis (2002) 1.14
8-methoxypsoralen plus ultraviolet A therapy acts via inhibition of the IL-23/Th17 axis and induction of Foxp3+ regulatory T cells involving CTLA4 signaling in a psoriasis-like skin disorder. J Immunol (2010) 1.13
Abscisic acid stimulates a calcium-dependent protein kinase in grape berry. Plant Physiol (2006) 1.12
Attenuated transforming growth factor beta signaling promotes nuclear factor-kappaB activation in head and neck cancer. Cancer Res (2009) 1.11
Same or different? A neural circuit mechanism of similarity-based pattern match decision making. J Neurosci (2011) 1.09
Linking microcircuit dysfunction to cognitive impairment: effects of disinhibition associated with schizophrenia in a cortical working memory model. Cereb Cortex (2012) 1.09
Mouse models for human head and neck squamous cell carcinomas. Head Neck (2006) 1.07
MicroRNA-31 is overexpressed in psoriasis and modulates inflammatory cytokine and chemokine production in keratinocytes via targeting serine/threonine kinase 40. J Immunol (2012) 1.07
Epidermal Smad4 deletion results in aberrant wound healing. Am J Pathol (2009) 1.06
K14-GLp65 transactivator induces transgene expression in embryonic epidermis. Genesis (2002) 1.06
MicroRNA-137 targets carboxyl-terminal binding protein 1 in melanoma cell lines. Int J Biol Sci (2011) 1.06
Hedgehog signaling alters reliance on EGF receptor signaling and mediates anti-EGFR therapeutic resistance in head and neck cancer. Cancer Res (2013) 1.06
Cannabinoid-mediated disinhibition and working memory: dynamical interplay of multiple feedback mechanisms in a continuous attractor model of prefrontal cortex. Cereb Cortex (2007) 1.06
Smad3 knockout mice exhibit a resistance to skin chemical carcinogenesis. Cancer Res (2004) 1.05
The role of Smads in skin development. J Invest Dermatol (2008) 1.04
Loss of serum response factor in keratinocytes results in hyperproliferative skin disease in mice. J Clin Invest (2009) 1.03
TMPRSS2- driven ERG expression in vivo increases self-renewal and maintains expression in a castration resistant subpopulation. PLoS One (2012) 1.03
The Arabidopsis Ca(2+) -dependent protein kinase CPK12 negatively regulates abscisic acid signaling in seed germination and post-germination growth. New Phytol (2011) 1.03
Regulation of Th1 and Th17 cell differentiation and amelioration of experimental autoimmune encephalomyelitis by natural product compound berberine. J Immunol (2010) 1.02
Tuning curve shift by attention modulation in cortical neurons: a computational study of its mechanisms. Cereb Cortex (2005) 1.02
Roles of TGFβ signaling Smads in squamous cell carcinoma. Cell Biosci (2011) 1.02
Free radical scavenging and antioxidant activities of EPS2, an exopolysaccharide produced by a marine filamentous fungus Keissleriella sp. YS 4108. Life Sci (2004) 1.02
Power-law neuronal fluctuations in a recurrent network model of parametric working memory. J Neurophysiol (2005) 1.01
Epithelial stem cell mutations that promote squamous cell carcinoma metastasis. J Clin Invest (2013) 1.01
Pharmacokinetics and short-term safety of 873140, a novel CCR5 antagonist, in healthy adult subjects. Antimicrob Agents Chemother (2005) 1.01
Dynamic hook-and-eye nanoparticle sponges. Nat Chem (2009) 1.00
Reconciling coherent oscillation with modulation of irregular spiking activity in selective attention: gamma-range synchronization between sensory and executive cortical areas. J Neurosci (2010) 1.00
Overexpression of the progestagen-associated endometrial protein gene is associated with microphthalmia-associated transcription factor in human melanoma. Ochsner J (2011) 0.99